NEW YORK (GenomeWeb) – Swedish drug discovery firm Pelago Bioscience and German proteomics firm OmicScouts today announced a collaboration to determine and quantify drug interactions using Pelago's cellular thermal shift assay (CETSA) technology.

Under the terms of the agreement, Pelago has licensed its CETSA technology to OmicScouts for mass spectrometric and proteomic applications for contract research projects. The firms will combine expertise and resources to offer target identification and validation services.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The Associated Press reports that the US government wasted $341,000 on travel by former Health and Human Services Secretary Tom Price.

Women who post YouTube science videos get more critical comments and more comments about their appearance than male video hosts, the New York Times reports.

The Wall Street Journal writes that participating in genetic research brings up the specter of past research ethics lapses for some African Americans.

In PLOS this week: sequences influencing yeast prion aggregation or degradation, dengue virus genetic variants affect transmission dynamics, and more.